Skip to main content

Shahab Toursavadkohi, MD

Academic Title:

Associate Professor

Primary Appointment:

Surgery

Location:

UMMC, Vascular Center, S10B

Phone (Primary):

410-328-5840

Fax:

410-328-0717

Education and Training

Education

  • 1994-2001: Doctor of Medicine, Tehran University of Medical Sciences. Tehran, Iran

 

Post-Doctoral Education and Training

  • 2005-2006: Internship, General Surgery, Union Memorial Hospital, Baltimore, MD
  • 2006-2011: Resident, General Surgery, Henry Ford Hospital, Detroit, MI
  • 2011-2013: Fellowship, Division of Vascular Surgery, University of Maryland Medical Center, Baltimore, MD

 

Certifications

  • 2008-Present   Fundamental of Microsurgery
  • 2011-present   Fundamental of Laparoscopic Surgery (FLS)
  • 2013-present   Registered Physician in Vascular Interpretation (RPVI)
  • 2014-present   Fenestrated endoprosthesis (Z-Fen) certificate
  • 2016-present   Thoracic Branch Endograft (TBE) certificate
  • 2018-present   Trans carotid artery revascularization (TCAR) certificate

Biosketch

At the University of Maryland, I have re-organized our main campus vascular surgery practice.  At the start of my tenure all surgeons were practicing as individual surgeons; however, during my time here I have changed this practice, instead creating a team of vascular surgeons. In doing so, I have created the first national Vascular Acute Case Surgery (VACS), modeling our team approach after Acute Care Surgery (ACS).  Under my supervision and leadership, VACS became fully staffed and capable of providing year-round, seven days per week, twenty-four hours per day services for all vascular emergencies presenting to our hospital. Our organization’s successes utilizing this team approach in managing vascular emergencies have been both presented at national meetings and also published in national journals.

As the co-director of the Aortic Center, we have developed a comprehensive, regionally recognized program which addresses the most complex aortic pathologies utilizing innovative endovascular and hybrid approaches. Utilizing these approaches has allowed me to collaborate with other surgeons at my institution in order to perform ground-breaking ascending aorta and aortic arch repairs on patients presenting with Type A aortic dissections or aortic aneurysms, whom were deemed unfit for an open cardiac repair. Our clinical experiences of these cases have been presented in two international meetings: Society of Thoracic Surgery (STS) and Society of Clinical Vascular Surgery (SCVS).

Since 2017, I have spearheaded the incorporation of the fenestrated and complex endovascular repair of thoracoabdominal and juxta-renal aortic aneurysm within our hospital. Performing these procedures has led to reduced morbidity, enhanced outcomes and increased our clinical volume and complexity to the point that UMMC has the largest market share within this domain.

Within the upcoming weeks I intend to launch our Branch Endograft Program at the University of Maryland Medical Center (UMMC). This will allow us to treat patients with aortic aneurysms involving the visceral branch vessels using the Thoracoabdominal Branch Endoprosthesis (TAMBE) device. We will not only be the first site within the state of Maryland to use this device, but also, we will be the first site on the entire eastern coast of the United States utilizing the TAMBE device in order to repair patients with complex aortic disease.

Additional Publication Citations

Research Interests

Awards and Affiliations

×